Technip FMC has been awarded a contract by the state-owned Hindustan Petroleum Corporation (HPCL) for a grassroot Hydrogen Generation Unit (HGU). The undisclosed value of the contract ranges between $ 250 and 500 million.

My, how you've grown! Micro- and millireactors bring process intensification in specialty chemistry and pharmacy — One of the current challenges facing the process industry is a change in product portfolio away from commodities to customer-specific specialties. The paradigm shift in process technology production from the batch principle to the continuous flow process based on micro- and millireactors offers great advantages in many cases and is now showing initial success on an industrial scale.

Evoqua Water Technologies teams up with Singapore’s national water agency PUB to demonstrate the viabiliyt of its next-generation electrochemical desalination module technology. Together, both partners plan a 500,000 gallons/day demonstration plant in Tuas, Singapore.

Gerresheimer is further expanding its presence on the South American market by starting production of pharmaceutical plastic packaging in the Brazilian state of Goiás.

Science, industry and politics are joining forces to turn exhaust gases into chemical raw materials —  Some 20 million tons of CO2 are at stake — this is the amount of greenhouse gas Germany's steelworks emit into the atmosphere every year. No surprise then that experts see great potential for the material use of waste gases. Can the mammoth project “smokestack chemistry” succeed? The Carbon2Chem conference is campaigning for a cooperation between the different players.

The Star Aegean Refinery in Izmir/Turkey is currently under construction. At the same time a hydrogen plant is to be built in the direct vicinity. The reformer will be delivered by Technip.

The US Drug Supply Chain Security Act and the EU Falsified Medicines Directive both contain similar basic requirements in terms of serialization. However, while the overall objective – a safer drug supply chain – is the same on both sides of the Atlantic, the respective regulations differ widely in many aspects.

Cipla enhances its filling capacities with a new capsule filling machine — GKF 2500 ASB 100% – The pharmaceutical industry in India is growing at a rapid pace. The shift from large medicine batches to more complex formulations has led to a high demand for sophisticated technologies. In parallel, pharmaceutical producers are expanding their export activities to North America and Europe, where they must meet stringent safety and quality regulations. Cipla, one of the largest Indian pharmaceutical manufacturing companies, has also experienced a boost in demand, and has enhanced its filling capacities with a new capsule filling machine—GKF 2500 ASB 100% from Bosch Packaging Technology.

Oxea announced that their new world-scale propanol production unit at its Bay City site in Texas, USA, is mechanically complete.

The production capacities of bio-based polymers continue to grow at around 3 to 4 % per annum, i.e. at about the same rate as petrochemical polymers. Therefore, the market share of bio-based polymers in the total polymer market remains constant at around 2 %. But the individual development of different bio-based polymers varies considerably.